BOIRON : Activity in 2017

HIGHLIGHTS OF THE FOURTH QUARTER

Sales revenue of the fourth quarter 2017 decreased by 1.1% (-0.4% at constant exchange rates). Sales of non-proprietary homeopathic medicines were down by 3.2%. Sales of OTC specialties were up by 1.1%, with a decrease of 13.3% in Russia and an increase of 2.3% in France and 13.2% in the USA.
Annual sales revenue amounted ?617,540 thousand and was stable in comparison to 2016 (+0.5% at current exchange rates and +0.1% at constant exchange rates).
The operating income of 2017 should be lower than in 2016.
Our company carries on the development of homeopathy in the world with the same determination.

Our next update: March 14, 2018, after the close of the stock market, publication of 2017 results.
(Actusnews)